Pig kidney transplant for kidney failure patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a special pig kidney (10 GE Xenokidney) as a transplant option for people with kidney failure who cannot get a human kidney. It aims to offer a life-saving alternative.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have end-stage renal disease (kidney failure) and have been on hemodialysis for at least 6 months.
- You need to be between 50 and 70 years old, or 40 to 49 with very high antibody levels (cPRA 99.9% or more).
- You must live within 3 hours of the transplant center.
- You need to be unable to get a standard human kidney transplant (either not eligible for a living donor, not on the national waiting list, or removed from it).
- You must have had certain vaccines (meningococcal, and be immune to CMV and Epstein-Barr viruses).
- You must not have other serious health problems like severe heart or lung disease, active cancer, or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment made from pig pancreatic cells (called OPF-310) that are placed under the skin to help control blood sugar in people with type 1 diabetes. It is for those whose diabetes is difficult to manage and who have dangerous low blood sugar episodes.
This trial tests a genetically modified pig kidney (Thymokidney) for people with end-stage kidney disease who are on dialysis. It aims to see if this new type of transplant is safe and effective for those who cannot get a human kidney.
This study tests different treatments for people with advanced kidney disease, including those on dialysis or with a kidney transplant. It aims to find better ways to manage the condition and improve outcomes.
This study tests a special way to keep and treat a donated kidney using a machine before it’s transplanted. The goal is to improve transplant outcomes for certain people on the kidney transplant waiting list.
This trial tests a new type of kidney transplant using a genetically modified pig kidney (called a xenograft). It is for people with end-stage kidney disease who have been on dialysis and are not likely to get a human donor kidney soon. The goal is to see if this pig kidney can work safely as an alternative.
This Phase 1 study tests a treatment plan (including rabbit medicine and a low dose of radiation) meant to help the new kidney “take” and work longer. It also includes a kidney-from-deceased-donor process and checks how safely the treatment works in people with end-stage kidney disease.
Hear when a new Kidney Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.